Evogene Ltd. Filing Becomes Effective
Ticker: EVGN · Form: EFFECT · Filed: Apr 6, 2026 · CIK: 0001574565
Sentiment: neutral
Topics: registration-statement, effectiveness, sec-filing
TL;DR
Evogene's filing is now live with the SEC, watch for potential stock moves.
AI Summary
Evogene Ltd. filed an EFFECT form on April 6, 2026, indicating the effectiveness of a registration statement. The filing, with accession number 9999999995-26-001076, relates to file number 333-282218 under the Securities Act of 1933. The company's business address is 13 Gad Feinstein Street, Park Rehovot, Israel.
Why It Matters
This filing signifies that a previously submitted registration statement is now effective, allowing for potential future securities offerings or transactions by Evogene Ltd.
Risk Assessment
Risk Level: low — An EFFECT filing itself is a procedural notification and does not inherently carry significant financial risk.
Key Numbers
- 2026-04-03 — Effectiveness Date (The date the registration statement became effective.)
- 2026-04-06 — Filing Acceptance Date (The date the SEC accepted the filing.)
Key Players & Entities
- Evogene Ltd. (company) — Filer
- 9999999995-26-001076 (dollar_amount) — SEC Accession Number
- 2026-04-06 (dollar_amount) — Acceptance Date
- 2026-04-03 (dollar_amount) — Effectiveness Date
- 333-282218 (dollar_amount) — File Number
FAQ
What is the purpose of an EFFECT filing?
An EFFECT filing signifies that a registration statement previously filed with the SEC has become effective, allowing for the sale of securities.
What is the accession number for this filing?
The SEC accession number for this filing is 9999999995-26-001076.
When did this filing become effective?
The filing became effective on April 3, 2026.
What is Evogene Ltd.'s business address?
Evogene Ltd.'s business address is 13 Gad Feinstein Street, Park Rehovot, Rehovot L3 7638517.
What is the file number associated with this registration statement?
The file number associated with this registration statement is 333-282218.
Filing Stats: 35 words · 1 min read · ~1 pages · Grade level 11.4 · Accepted 2026-04-06 00:15:04
Filing Documents
- primary_doc.html (EFFECT)
- primary_doc.xml (EFFECT) — 1KB
- 9999999995-26-001076.txt ( ) — 2KB
From the Filing
Notice of Effectiveness UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Notice of Effectiveness Effectiveness Date: April 3, 2026 Submission Type: POS AM CIK: Company Name: Evogene Ltd. File Number: 333-282218